Roche CoaguChek INRange INR Self-Testing Meter with Bluetooth

Roche CoaguChek INR Machine for Patient Self-Monitoring

The Roche CoaguChek INRange is a portable INR self-testing meter designed for patients on vitamin K antagonist (VKA) therapy. The device supports patient self-monitoring of prothrombin time and INR levels in home and community settings.

The meter uses CoaguChek technology and features Bluetooth connectivity for transmission of PT/INR results to healthcare providers. The device is battery-operated and compatible with CoaguChek test strips.

NICE recommends self-monitoring for suitable patients on long-term oral anticoagulation therapy. The meter includes colour-coded display, customisable therapeutic range settings, and on-screen testing guidance.

Product Features

• Portable INR monitoring meter for VKA therapy self-testing
• Bluetooth and USB connectivity for result transmission
• Colour-coded display with target range alerts
• Customisable therapeutic range settings
• Results trend reporting function
• Test, medication, and appointment reminder settings
• Comment functionality for up to 6 notes per result
• On-screen guidance throughout testing procedure
• Battery-operated for portability

Product Specifications

• Brand: Roche Diagnostics
• Product: CoaguChek INRange INR Meter
• Power: 4 x AAA batteries (included)
• Connectivity: Bluetooth and USB
• Test Strips: Compatible with CoaguChek test strips (W07019, sold separately)
• Clinical Use: Patient self-monitoring of INR on VKA therapy
• Compliance: NICE recommended for self-monitoring
• Kit Contents: CoaguChek meter, 4 x AAA batteries, Softclix finger pricker, 20 Softclix XL lancets, carry case, user manual

View our INR Testing range to support ongoing anticoagulation monitoring for your patients.

Frequently Asked Questions

What patient self-testing products does Roche offer?

Roche provides the CoaguChek XS and CoaguChek INRange systems for patient self-testing (PST). 

Within a primary care framework, these devices allow patients on long-term Vitamin K Antagonist (VKA) therapy, such as Warfarin, to monitor their International Normalised Ratio (INR) from home. 

The INRange model is specifically designed for patient use, featuring Bluetooth connectivity and built-in trend reports to support patient self-management under clinical supervision.

How can CoaguChek meters connect to patient records?

The CoaguChek Pro II and CoaguChek INRange support data transfer via wireless or Bluetooth functionality, depending on configuration.

In UK primary care settings, integration with clinical systems typically requires approved middleware solutions such as cobas IT 1000 or other locally supported connectivity platforms. Implementation depends on individual practice IT infrastructure and POCT governance arrangements.

Digital transfer can support structured result capture and reduce reliance on manual transcription, subject to appropriate system configuration and validation.

What are the key benefits of using Roche's INR monitoring systems?

The primary clinical function of Roche INR monitoring systems is to provide rapid International Normalised Ratio (INR) results at the point of care using a capillary blood sample of approximately 8 µL.

For primary care teams, this can support same-visit clinical decision-making and reduce reliance on venous sampling pathways where appropriate. Devices are designed to deliver results that align with manufacturer performance specifications for point-of-care INR testing.

Increased testing frequency in patients on long-term Vitamin K Antagonist therapy has been associated in published literature with improved Time in Therapeutic Range (TTR). Maintenance of therapeutic INR ranges is clinically linked to reduced thromboembolic and haemorrhagic risk, although outcomes depend on individual patient management and adherence.

How do patients rate the convenience of Roche's self-testing tools?

Patient self-testing systems such as the CoaguChek INRange are designed to enable INR monitoring outside of the clinical setting under appropriate supervision.

Finger-prick capillary sampling may reduce the need for routine venepuncture and in-person appointments, which can be relevant for patients with mobility limitations or those in remote community settings.

The INRange device includes on-screen trend and Time in Range displays to support patient awareness of INR stability. Ongoing suitability for self-testing should be determined through structured patient assessment and clinical oversight.